Search

"immunity" - search results

If you're not happy with the results, please do another search

COVID-19 Community Immunity for All Initiative at Atrium Health

Scott Rissmiller, MD, EVP & Chief Physician Executive, and Kinneil Coltman, DHA, SVP, Chief Community & Social Impact Officer, Atrium Health. Atrium Health’s “Community Immunity For All” collaborative has a united goal to ensure equity in access to COVID-19 vaccines, acknowledge the history of health injustice in communities of color, listen to and collaborate with partner organizations, and support...

COVID-19 Immunity Research at Mass General Brigham

Duane Wesemann, MD, PhD, Associate Professor of Medicine, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital. It is relatively well-known that the immune system produces antibodies in response to COVID-19 infection, but how long these antibody responses last continues to be unclear, and the heterogeneity of immune responses to COVID-19 makes it difficult to develop predictive models. Dr....

Study: Robust T-Cell Immunity Found in Those with Asymptomatic, Mild COVID-19

Marcus Buggert, PhD, Assistant Professor, Department of Medicine Huddinge, Karolinska Institute, Sweden.  Dr. Buggert is a viral immunologist that has focused his career on T cells in the context of HIV infection. During this teleconference, Dr. Buggert describes the most recent data on T cell immunity in COVID-19 patients. Additionally, he provides an update on the "knowns" and "unknowns"...

WEBINAR | Creative Responses to COVID-19:  Automatic Vaccination Billing, Drive Up Antibody Infusions and EMR Interoperability

David Pape, VP, Technology, Palomar Health; Kurt Romeiser, Senior Clinical Informaticist, Tiger Institute Health Alliance; Prudence Myers, MHA, CPhT, Sr. Decision Support Analyst, University Physicians Revenue Integrity, Plan Administration, University of Missouri Health Care; and Dick Flanigan, MBA, FACHE, SVP,  Cerner. Healthcare organizations are finding creative ways to handle COVID-19 surges and vaccinate members of the community.  At the University...

COVID-19 Seropositivity and Asymptomatic Rates in Healthcare Workers at Beaumont

Hans Keil, MBA, SVP & CIO, and Matthew Sims, MD, PhD, Director of Infectious Disease Research, Beaumont Health.  Beaumont Health conducted a major study of over 20,000 employees during the height of last spring’s COVID-19 surge, leveraging their IT and Lab teams, to understand the risk of exposure for frontline healthcare workers.  Determining infection rate can be difficult due...

Michael Czumak, III

Michael Czumak
VP and CISO at Memorial Sloan Kettering Cancer Center I have over 11 years experience in IT and Information Security. My primary role is developing and leading an application security and penetration testing program, performing hands-on testing of a variety of systems, devices, and applications (web, desktop and mobile applications, medical devices, etc). My primary areas of interest and core competencies...